"The U.S. Food and Drug Administration today expanded the approved use of Xgeva (denosumab) to treat adults and some adolescents with giant cell tumor of the bone (GCTB), a rare and usually non-cancerous tumor.
GCTB generally occurs in a"...
(Generic versions may still be available.)
- Clinician Information:
Vira-A Patient Information Including Side Effects
Brand Names: Vira-A
Generic Name: vidarabine ophthalmic (Pronunciation: vye DARE a been)
- What is vidarabine ophthalmic (Vira-A)?
- What are the possible side effects of vidarabine ophthalmic (Vira-A)?
- What is the most important information I should know about vidarabine ophthalmic (Vira-A)?
- What should I discuss with my healthcare provider before using vidarabine ophthalmic (Vira-A)?
- How should I use vidarabine ophthalmic (Vira-A)?
- What happens if I miss a dose (Vira-A)?
- What happens if I overdose (Vira-A)?
- What should I avoid while using vidarabine ophthalmic (Vira-A)?
- What other drugs will affect vidarabine ophthalmic (Vira-A)?
- Where can I get more information?
What is vidarabine ophthalmic (Vira-A)?
Vidarabine is an antiviral medication. The exact way that vidarabine works against viruses in the eye is unknown.
Vidarabine ophthalmic is used to treat eye infections caused by the herpes virus.
Vidarabine ophthalmic may also be used for purposes other than those listed in this medication guide.
What are the possible side effects of vidarabine ophthalmic (Vira-A)?
Serious side effects are not expected to occur with the use of this medication.
Commonly, some burning, stinging, pain, irritation, itching, redness, blurred vision, tearing, or sensitivity to light may occur. Continue to use vidarabine and talk to your doctor about any side effects that you experience.
Read the Vira-A (vidarabine) Side Effects Center for a complete guide to possible side effects
What is the most important information I should know about vidarabine ophthalmic (Vira-A)?
Contact your doctor if your symptoms begin to get worse or if you do not see any improvement after a few days.
Do not touch the tube opening to any surface, including the eyes or hands. The tube opening is sterile. If it becomes contaminated, it could cause an infection in the eye.
Vidarabine ophthalmic may increase eye sensitivity to bright light. Wear sunglasses to prevent irritation.
Additional Vira-A Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.